A study on the expression and prognostic value of TLRs in pancreatic cancer patients treated with neoadjuvant therapy demonstrated that both TLR7 and TLR9 predicted a favorable postoperative outcome in a separate analysis adjusted for background variables [48]. The gene discussed is TLR7; the disease is pancreatic neoplasm.